Cortisol (hydrocortisone) NDC 43742-1275

NDC codes

FDA NDC Directory

Product NDC (as listed)43742-1275Labeler and product segments. Claims need a package NDC.

Product NDC at billing width43742-1275Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
43742-1275-1	43742127501	30 mL in 1 BOTTLE, DROPPER (43742-1275-1)Marketed from Jul 20, 2018

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Cortisol
Generic name (nonproprietary): hydrocortisone
Active ingredients: Hydrocortisone — 8 [hp_X]/mL
Dosage form: Liquid
Route: Oral
Labeler: Deseret Biologicals, Inc.
Product type: Over-the-counter drug
Marketing category: Unapproved homeopathic
Marketing start: Jul 20, 2018
Listing expires: Dec 31, 2026
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 43742-1275_a8bf9300-301f-4c9b-b924-cb97d9ccc4c5SPL ID a8bf9300-301f-4c9b-b924-cb97d9ccc4c5SPL set ID 32ae980b-5a01-4d08-885a-1c0a8fbfbb2eUNII WI4X0X7BPJUPC 0810151880105
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N443742127501 followed by a unit qualifier and the quantity

Package 43742-1275-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 6, 2024.

Indications (excerpt from the label)

USES: • For the temporary relief of symptoms including: • joint aches • fatigue • low energy These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)